Patents by Inventor Mitsuo Sakoh

Mitsuo Sakoh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4996299
    Abstract: Disclosed is a method for preparing pertussis toxin toxoid by a treatment pertussis toxin with formaldehyde, which comprises carrying out said treatment in the presence of lysine or glycine in combination with N-acetyltriptophan. The resultant toxoid does not exhibit toxicity reversion, thereby making the toxoid highly suitable for use in pertussis vaccines.
    Type: Grant
    Filed: November 28, 1989
    Date of Patent: February 26, 1991
    Assignee: Juridical Foundation The Chemo-Sero-Therapeutic Research Institute
    Inventors: Akihiro Ginnaga, Kazunori Morokuma, Katsutoshi Aihara, Mitsuo Sakoh
  • Patent number: 4885359
    Abstract: Improved method for the purification of LPF-HA (Leucocytosis promoting far hemagglutinin) on industrial scale which comprises contacting a LPF-HA-containing solution from culture media of Bordetella pertussis with a cellulose sulfate gel, a crosslinked polysaccharide sulfate gel, or a polysaccharide gel chemically bound with dextran sulfate, thereby adsorbing LPF-HA on the gel, and then eluting LPF-HA from the gel. Said method can give a highly purified LPF-HA which does not contain any other proteins, lipid, saccharides, etc. and further undesirable endotoxin, and hence can be used for producing various reagents, medicines and pertussis vaccine.
    Type: Grant
    Filed: November 16, 1987
    Date of Patent: December 5, 1989
    Assignee: Juridical Foundation The Chemo-Sero-Therapeutic Research Institute
    Inventors: Akihiro Ginnaga, Tsukasa Nishihara, Tetsuo Kawahara, Sadao Susumi, Hiroshi Mizokami, Mitsuo Sakoh
  • Patent number: 4725547
    Abstract: Disclosed is a method for the purification of rabic virus, which comprises subjecting a solution containing the rabic virus to column chromatography using, as a gel for chromatography, a sulfuric acid ester of cellulose or a crosslinked polysaccharide. The method can provide highly purified rabic virus which is useful for obtaining an effective vaccine against rabies.
    Type: Grant
    Filed: August 9, 1985
    Date of Patent: February 16, 1988
    Assignee: Juridical Foundation The Chemo-Sero-Therapeutic Research Institute
    Inventors: Kuniaki Sakamoto, Kunio Ohkuma, Tetsuo Kawahara, Mitsuo Sakoh
  • Patent number: 4725546
    Abstract: Disclosed is a method for the purification of Japanese encephalitis virus, which comprises subjecting a solution containing the Japanese encephalitis virus to column chromatography using, as a gel for chromatography, a sulfuric acid ester of cellulose or a crosslinked polysaccharide. The method can provide highly purified Japanese encephalitis virus, which is useful for obtaining an effective vaccine against Japanese encephalitis.
    Type: Grant
    Filed: August 9, 1985
    Date of Patent: February 16, 1988
    Assignee: Juridical Foundation The Chemo-Sero-Therapeutic Research Institute
    Inventors: Kuniaki Sakamoto, Isao Gotoh, Tetsuo Kawahara, Mitsuo Sakoh
  • Patent number: 4724210
    Abstract: Disclosed is a method for the purification of an influenza virus, which comprises subjecting a solution containing the influenza virus to column chromatography using, as a gel for chromatography, a sulfuric acid ester of cellulose or a crosslinked polysaccharide. The method can provide highly purified influenza virus which is useful for obtaining an effective vaccine against influenza.
    Type: Grant
    Filed: August 9, 1985
    Date of Patent: February 9, 1988
    Assignee: Juridical Foundation the Chemo-Sero-Therapeutic Research Institute
    Inventors: Tetsuya Oka, Kunio Ohkuma, Tetsuo Kawahara, Mitsuo Sakoh
  • Patent number: 4704274
    Abstract: A method for producing highly pure LPF-HA (Leucocytosis-promoting Factor agglutinin) from culture media of Bordetella pertussis in a high yield by an affinity chromatography using a denatured ceruloplasmin as a ligand. The LPF-HA obtained by this invention is highly pure and does not contain almost endotoxin of B. pertussis and is useful for the preparation of various reagents utilizing the physiological activities, a medicine for treating diabetes, and a pertussis vaccine.
    Type: Grant
    Filed: October 26, 1984
    Date of Patent: November 3, 1987
    Assignee: Juridical Foundation The Chemo-Sero-Therapeutic Research Institute
    Inventors: Shin Sakuma, Kuniaki Sakamoto, Hisashi Kitagawa, Mitsuo Sakoh, Saneo Nonaka